Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark

Sidsel Arnspang Pedersen; David Gaist; Sigrun Alba Johannesdottir Schmidt; Lisbet Rosenkrantz Holmich; Søren Friis; Anton Pottegard

doi:10.1016/j.jaad.2017.11.042

Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark

Sidsel Arnspang Pedersen, David Gaist, Sigrun Alba Johannesdottir Schmidt, Lisbet Rosenkrantz Holmich, Søren Friis, Anton Pottegard

114 Citations (Scopus)

73 Downloads (Pure)

Original language	English
Article number	e9
Journal	Journal of the American Academy of Dermatology
Volume	78
Issue number	4
Pages (from-to)	673-681
Number of pages	9
ISSN	0190-9622
DOIs	https://doi.org/10.1016/j.jaad.2017.11.042
Publication status	Published - Apr 2018

Keywords

antihypertensives
cancer risk
hydrochlorothiazide
nonmelanoma skin cancer
pharmaco-epidemiology
pharmacology
skin cancer

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jaad.2017.11.042Licence: CC BY

Hydrochlorothiazide use and risk of nonmelanoma skin cancerFinal published version, 502 KBLicence: CC BY

Cite this

Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark. / Pedersen, Sidsel Arnspang; Gaist, David; Schmidt, Sigrun Alba Johannesdottir et al.
In: Journal of the American Academy of Dermatology, Vol. 78, No. 4, e9, 04.2018, p. 673-681.

Research output: Contribution to journal › Journal article › Research › peer-review

@article{429b87aebdac451c950b97594977ec2b,

title = "Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark",

keywords = "antihypertensives, cancer risk, hydrochlorothiazide, nonmelanoma skin cancer, pharmaco-epidemiology, pharmacology, skin cancer",

author = "Pedersen, {Sidsel Arnspang} and David Gaist and Schmidt, {Sigrun Alba Johannesdottir} and Holmich, {Lisbet Rosenkrantz} and S{\o}ren Friis and Anton Pottegard",

year = "2018",

month = apr,

doi = "10.1016/j.jaad.2017.11.042",

language = "English",

volume = "78",

pages = "673--681",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Mosby Inc.",

number = "4",

}

TY - JOUR

T1 - Hydrochlorothiazide use and risk of nonmelanoma skin cancer

T2 - A nationwide case-control study from Denmark

AU - Pedersen, Sidsel Arnspang

AU - Gaist, David

AU - Schmidt, Sigrun Alba Johannesdottir

AU - Holmich, Lisbet Rosenkrantz

AU - Friis, Søren

AU - Pottegard, Anton

PY - 2018/4

Y1 - 2018/4

KW - antihypertensives

KW - cancer risk

KW - hydrochlorothiazide

KW - nonmelanoma skin cancer

KW - pharmaco-epidemiology

KW - pharmacology

KW - skin cancer

U2 - 10.1016/j.jaad.2017.11.042

DO - 10.1016/j.jaad.2017.11.042

M3 - Journal article

C2 - 29217346

SN - 0190-9622

VL - 78

SP - 673

EP - 681

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 4

M1 - e9

ER -

Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this